Germ cell tumours of the testis: 10-year survival data from a tertiary care centre in India

This publication has 34 references indexed in Scilit:

• Serum tumor markers and their utilization in the management of germ-cell tumors in adult males
  Expert Review of Anticancer Therapy, 2011
• Prognostic features and markers for testicular cancer management
  Indian Journal of Urology, 2010
• Current status of chemotherapy in risk‐adapted management for metastatic testicular germ cell cancer
  Cancer Science, 2009
• Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse
  British Journal of Cancer, 2008
• Evidence‐based guidelines for following stage 1 seminoma
  Cancer, 2007
• Fertility after testicular cancer treatments
  Cancer, 2004
• Clinical Pattern and Therapeutic Results Achieved in 1490 Patients with Germ-Cell Tumours of the Testis: the Experience of the Spanish Germ-Cell Cancer Group (GG)
  European Urology, 2002
• Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council
  Journal of Clinical Oncology, 2001
• Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience.
  Journal of Clinical Oncology, 1998
• International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
  Journal of Clinical Oncology, 1997